መነሻ4DX • ASX
add
4DMedical Ltd
የቀዳሚ መዝጊያ
$0.50
የቀን ክልል
$0.53 - $0.56
የዓመት ክልል
$0.41 - $0.83
የገበያው አጠቃላይ ዋጋ
217.02 ሚ AUD
አማካይ መጠን
953.90 ሺ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
ASX
ዜና ላይ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(AUD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 1.48 ሚ | 1,172.70% |
የሥራ ወጪ | 12.56 ሚ | 11.42% |
የተጣራ ገቢ | -10.19 ሚ | -33.78% |
የተጣራ የትርፍ ክልል | -687.84 | 89.49% |
ገቢ በሼር | — | — |
EBITDA | -11.09 ሚ | -5.51% |
ውጤታማ የግብር ተመን | -0.01% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(AUD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 30.61 ሚ | -56.01% |
አጠቃላይ ንብረቶች | 120.02 ሚ | 29.16% |
አጠቃላይ ተጠያቂነቶች | 49.09 ሚ | 128.71% |
አጠቃላይ እሴት | 70.93 ሚ | — |
የሼሮቹ ብዛት | 410.53 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 2.91 | — |
የእሴቶች ተመላሽ | -23.28% | — |
የካፒታል ተመላሽ | -36.73% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(AUD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | -10.19 ሚ | -33.78% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | -8.06 ሚ | 8.54% |
ገንዘብ ከኢንቨስትመንት | -339.48 ሺ | -21.29% |
ገንዘብ ከፋይናንስ | -233.98 ሺ | -101.11% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | -8.64 ሚ | -172.48% |
ነፃ የገንዘብ ፍሰት | -5.43 ሚ | 13.25% |
ስለ
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
2013
ድህረገፅ
ሠራተኞች
145